-
公开(公告)号:US06184376B2
公开(公告)日:2001-02-06
申请号:US09130214
申请日:1998-08-06
申请人: M. Robert Leanna , Steven M. Hannick , Michael Rasmussen , Jien-Heh J. Tien , Lakshmi Bhagavatula , Pulla Reddy Singam , Bradley D. Gates , Lawrence Kolaczkowski , Ramesh R. Patel , Greg Wayne , Greg Lannoye , Weijiang Zhang , Zhenping Tian , Kirill A. Lukin , Bikshandarkoil A. Narayanan , David A. Riley , Howard Morton , Sou-Jen Chang , Cynthia B. Curty , Daniel Plata , John Bellettini , Bhadra Shelat , Tiffany Spitz , Cheng-Xi Yang
发明人: M. Robert Leanna , Steven M. Hannick , Michael Rasmussen , Jien-Heh J. Tien , Lakshmi Bhagavatula , Pulla Reddy Singam , Bradley D. Gates , Lawrence Kolaczkowski , Ramesh R. Patel , Greg Wayne , Greg Lannoye , Weijiang Zhang , Zhenping Tian , Kirill A. Lukin , Bikshandarkoil A. Narayanan , David A. Riley , Howard Morton , Sou-Jen Chang , Cynthia B. Curty , Daniel Plata , John Bellettini , Bhadra Shelat , Tiffany Spitz , Cheng-Xi Yang
IPC分类号: C07D47318
CPC分类号: C07D473/00 , C07C309/73 , C07D473/18 , Y02P20/55
摘要: Methods and novel intermediates of the formula: wherein R6 and R7 are lower alkyl or benzyl or R6 and R7 taken together are —CH2CH2—, —CH2CH2CH2— or —CH2CH2CH2CH2CH2—, R8 is C1-C21 alkyl or a C2-C21 monounsaturated alkenyl, which may optionally be substituted with substitution substituents independently selected from the group consisting of hydroxy, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkoxy C1-C6 alkyl, C1-C6 alkanoyl, amino, halo, cyano, azido, oxo, mercapto and nitro, and R9 is an alcohol protecting group. The intermediates are useful for the preparation of acyclic nucleoside derivatives of the formula: where one of R1 and R2 is an amino acid acyl group and the other of R1 and R2 is a —C(O)C3-C21 saturated or monounsaturated, optionally substituted alkyl and R3 is OH or H; or a pharmaceutically acceptable salt thereof.
摘要翻译: 下式的方法和新型中间体:其中R6和R7是低级烷基或苄基或R6和R7一起是-CH 2 CH 2 - , - CH 2 CH 2 CH 2 - 或-CH 2 CH 2 CH 2 CH 2 CH 2 - ,R 8是C 1 -C 21烷基或C 2 -C 21单不饱和链烯基, 其可以任选地被独立地选自羟基,C 1 -C 6烷基,C 1 -C 6烷氧基,C 1 -C 6烷氧基C 1 -C 6烷基,C 1 -C 6烷酰基,氨基,卤素,氰基,叠氮基,氧代 ,巯基和硝基,R9是醇保护基。 中间体可用于制备下式的无环核苷衍生物:其中R 1和R 2中的一个是氨基酸酰基,R 1和R 2中的另一个是-C(O)C 3 -C 21饱和或单不饱和的,任选取代的 烷基和R 3是OH或H; 或其药学上可接受的盐。
-
公开(公告)号:US07189849B2
公开(公告)日:2007-03-13
申请号:US11131646
申请日:2005-05-18
申请人: M. Robert Leanna , Michael Rasmussen , Steven M. Hannick , Jien-Heh J. Tien , Kirill A. Lukin , Zhenping Tian , Sou-Jen Chang , Cynthia B. Curty , Bikshandarkoil A. Narayanan , John Bellettini , Bhadra Shelat , Tiffany Spitz
发明人: M. Robert Leanna , Michael Rasmussen , Steven M. Hannick , Jien-Heh J. Tien , Kirill A. Lukin , Zhenping Tian , Sou-Jen Chang , Cynthia B. Curty , Bikshandarkoil A. Narayanan , John Bellettini , Bhadra Shelat , Tiffany Spitz
IPC分类号: C07D473/18 , C07D473/40 , C07F7/18 , C07C69/66
CPC分类号: C07D473/00 , C07C309/73 , C07D473/18 , Y02P20/55
摘要: Novel processes towards the synthesis of the antiviral valomaciclovir stearate in which an esterified guanine acetal is reduced to the corresponding alcohol, reacted with an activated amino acid and N-deprotected. The esterified guanine acetal is prepared from a 9-guanine derivative bearing an acyclic hydroxymethylbutylacetal. The processes are amendable to one-pot reactions.
摘要翻译: 合成抗病毒伐莫西洛维硬脂酸酯的新方法,其中将酯化的鸟嘌呤缩醛还原成相应的醇,与活化的氨基酸反应并进行N-去保护。 酯化鸟嘌呤缩醛由带有无环羟甲基丁缩醛的9-鸟嘌呤衍生物制备。 这些过程可以修改为一锅反应。
-
公开(公告)号:US20050250795A1
公开(公告)日:2005-11-10
申请号:US11131646
申请日:2005-05-18
申请人: M. Leanna , Steven Hannick , Michael Rasmussen , Jien-Heh Tien , Lakshmi Bhagavatula , Pulla Singam , Bradley Gates , Lawrence Kolaczkowski , Ramesh Patel , Greg Wayne , Greg Lannoye , Weijiang Zhang , Zhenping Tian , Kirill Lukin , Bikshandarkoil Narayanan , David Riley , Howard Morton , Sou-Jen Chang , Cynthia Curty , Daniel Plata , John Bellettini , Bhadra Shelat , Tiffany Spitz , Cheng-Xi Yang
发明人: M. Leanna , Steven Hannick , Michael Rasmussen , Jien-Heh Tien , Lakshmi Bhagavatula , Pulla Singam , Bradley Gates , Lawrence Kolaczkowski , Ramesh Patel , Greg Wayne , Greg Lannoye , Weijiang Zhang , Zhenping Tian , Kirill Lukin , Bikshandarkoil Narayanan , David Riley , Howard Morton , Sou-Jen Chang , Cynthia Curty , Daniel Plata , John Bellettini , Bhadra Shelat , Tiffany Spitz , Cheng-Xi Yang
IPC分类号: C07D473/18 , A61K31/522 , C07B53/00 , C07B61/00 , C07C303/30 , C07C309/45 , C07C309/73 , C07D473/00 , C07D473/12 , C07D473/32 , C07D473/40
CPC分类号: C07D473/00 , C07C309/73 , C07D473/18 , Y02P20/55
摘要: Methods and novel intermediates for the preparation of acyclic nucleoside derivatives of the formula: where one of R1 and R2 is an amino acid acyl group and the other of R1 and R2 is a —C(O)C3-C21 saturated or monounsaturated, optionally substituted alkyl and R3 is OH or H; or a pharmaceutically acceptable salt thereof.
摘要翻译: 用于制备下式的无环核苷衍生物的方法和新型中间体:其中R 1和R 2中的一个是氨基酸酰基,另一个是R 1和R 2是-C(O)C 3 -C 21饱和或单不饱和的任选取代的烷基和 R 3是OH或H; 或其药学上可接受的盐。
-
公开(公告)号:US20050107364A1
公开(公告)日:2005-05-19
申请号:US10925072
申请日:2004-08-24
申请人: Douglas Hutchinson , John Bellettini , David Betebenner , Richard Bishop , Thomas Borchardt , Todd Bosse , Russell Cink , Charles Flentge , Bradley Gates , Brian Green , Mira Hinman , Peggy Huang , Larry Klein , Allan Krueger , Daniel Larson , M. Leanna , Dachun Liu , Darold Madigan , Keith McDaniel , John Randolph , Todd Rockway , Teresa Rosenberg , Kent Stewart , Vincent Stoll , Rolf Wagner , Ming Yeung
发明人: Douglas Hutchinson , John Bellettini , David Betebenner , Richard Bishop , Thomas Borchardt , Todd Bosse , Russell Cink , Charles Flentge , Bradley Gates , Brian Green , Mira Hinman , Peggy Huang , Larry Klein , Allan Krueger , Daniel Larson , M. Leanna , Dachun Liu , Darold Madigan , Keith McDaniel , John Randolph , Todd Rockway , Teresa Rosenberg , Kent Stewart , Vincent Stoll , Rolf Wagner , Ming Yeung
IPC分类号: A61K31/549 , C07D285/26
CPC分类号: C07D207/08 , C07C323/22 , C07C323/56 , C07C323/60 , C07C2601/02 , C07C2601/04 , C07C2601/08 , C07C2601/14 , C07C2602/10 , C07D263/14 , C07D285/24 , C07D417/06 , C07D417/08 , C07D417/12 , C07D513/04 , C07F9/6547
摘要: Compounds having the formula are hepatitis C (HCV) polymerase inhibitors. Also disclosed are a composition and method for inhibiting hepatitis C (HCV) polymerase, processes for making the compounds, and synthetic intermediates employed in the processes.
摘要翻译: 具有下式的化合物是丙型肝炎(HCV)聚合酶抑制剂。 还公开了用于抑制丙型肝炎(HCV)聚合酶,制备该化合物的方法和该方法中使用的合成中间体的组合物和方法。
-
-
-